Elevated IRAK1 phosphorylation levels are linked to breast cancer recurrence, highlighting the significant role of IRAK1-directed NF-κB signaling in breast cancer metastasis, resistance to chemotherapy, and tumor reappearance. Here, NFKB1 is linked to neoplasm.